Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Guthrie Da"'
Autor:
Werner C, Andreas T. Sørensen, Ulrik Gether, Guthrie Da, Freja Herborg, Ejdrup Al, Jonatan Fullerton Støier, Sauer M, Haahr No, Amy Hauck Newman, Lycas, Søren H. Jørgensen
The nanoscopic organization and regulation of individual molecular components in presynaptic varicosities of neurons releasing modulatory volume neurotransmitters like dopamine (DA) remain largely elusive. Here we show by application of several singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6085b39e7aaaca7e3522a42e579d9764
https://doi.org/10.1101/2021.03.09.434538
https://doi.org/10.1101/2021.03.09.434538
Publikováno v:
Medical Journal of Australia. 1:621-624
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sorkina T; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Bagalkot T; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Cheng MH; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Guthrie DA; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute of Drug Abuse-Intramural Research Program, Baltimore, MD, USA., Newman AH; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute of Drug Abuse-Intramural Research Program, Baltimore, MD, USA., Watkins SC; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Sorkin A; Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Publikováno v:
Science advances [Sci Adv] 2024 Nov 22; Vol. 10 (47), pp. eadq9793. Date of Electronic Publication: 2024 Nov 22.
Autor:
Lycas MD; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Ejdrup AL; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Sørensen AT; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Haahr NO; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Jørgensen SH; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Guthrie DA; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA., Støier JF; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Werner C; Department of Biotechnology and Biophysics, Biocenter, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany., Newman AH; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA., Sauer M; Department of Biotechnology and Biophysics, Biocenter, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany., Herborg F; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark., Gether U; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Maersk Tower 7.5, 2200 Copenhagen, Denmark. Electronic address: gether@sund.ku.dk.
Publikováno v:
Cell reports [Cell Rep] 2022 Sep 27; Vol. 40 (13), pp. 111431.
Autor:
Serena TE; SerenaGroup Research Foundation, Cambridge, Massachusetts, USA., Bayliff SW; WoundChek Labs, Gargrave, UK., Brosnan PJ; WoundChek Labs, Gargrave, UK., DiMarco DT; St Vincent's Health Center, Bridgeport, Connecticut, USA., Doner BA; D&P Medical Group, McCandless, Pennsylvania, USA., Guthrie DA; Chambersburg Hospital, Chambersburg, Pennsylvania, USA., Patel KD; D&P Medical Group, McCandless, Pennsylvania, USA., Sabo MJ; Foot and Ankle Wellness Center of Western PA, Ford City, Pennsylvania, USA., Samies JH; Palmetto Infectious Disease, Columbia, South Carolina, USA., Carter MJ; Strategic-Solutions Inc, Newark, Delaware, USA.
Publikováno v:
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society [Wound Repair Regen] 2021 Sep; Vol. 29 (5), pp. 752-758. Date of Electronic Publication: 2021 May 31.
Autor:
Camacho-Hernandez GA; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institutes of Drug Abuse - Intramural Research Program Baltimore MD 21224 USA anewman@intra.nida.nih.gov., Casiraghi A; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institutes of Drug Abuse - Intramural Research Program Baltimore MD 21224 USA anewman@intra.nida.nih.gov.; Department of Pharmaceutical Sciences, University of Milan Via Mangiagalli 25 20133 Milan Italy., Rudin D; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna Waehringer Strasse 13a 1090 Vienna Austria., Luethi D; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna Waehringer Strasse 13a 1090 Vienna Austria.; Institute of Applied Physics TU Wien, Lehárgasse 6 1060 Vienna Austria., Ku TC; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institutes of Drug Abuse - Intramural Research Program Baltimore MD 21224 USA anewman@intra.nida.nih.gov., Guthrie DA; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institutes of Drug Abuse - Intramural Research Program Baltimore MD 21224 USA anewman@intra.nida.nih.gov., Straniero V; Department of Pharmaceutical Sciences, University of Milan Via Mangiagalli 25 20133 Milan Italy., Valoti E; Department of Pharmaceutical Sciences, University of Milan Via Mangiagalli 25 20133 Milan Italy., Schütz GJ; Institute of Applied Physics TU Wien, Lehárgasse 6 1060 Vienna Austria., Sitte HH; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna Waehringer Strasse 13a 1090 Vienna Austria., Newman AH; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institutes of Drug Abuse - Intramural Research Program Baltimore MD 21224 USA anewman@intra.nida.nih.gov.
Publikováno v:
RSC medicinal chemistry [RSC Med Chem] 2021 Jun 09; Vol. 12 (7), pp. 1174-1186. Date of Electronic Publication: 2021 Jun 09 (Print Publication: 2021).
Autor:
Guthrie DA; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States., Klein Herenbrink C; Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Lycas MD; Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Ku T; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States., Bonifazi A; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States., DeVree BT; Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Mathiasen S; Department of Psychiatry, Columbia University Vagelos College of Physicians & Surgeon and Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, United States., Javitch JA; Department of Psychiatry, Columbia University Vagelos College of Physicians & Surgeon and Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, United States., Grimm JB; Janelia Research Campus, Howard Hughes Medical Institute, 19700 Helix Drive, Ashburn, Virginia 20147, United States., Lavis L; Janelia Research Campus, Howard Hughes Medical Institute, 19700 Helix Drive, Ashburn, Virginia 20147, United States., Gether U; Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark., Newman AH; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2020 Oct 21; Vol. 11 (20), pp. 3288-3300. Date of Electronic Publication: 2020 Oct 01.
Autor:
Bhat S; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Waehringerstrasse 13a, Vienna 1090, Austria., Guthrie DA; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States., Kasture A; Department of Neurobiology, University of Vienna, Vienna 1090, Austria., El-Kasaby A; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Waehringerstrasse 13a, Vienna 1090, Austria., Cao J; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States., Bonifazi A; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States., Ku T; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States., Giancola JB; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States., Hummel T; Department of Neurobiology, University of Vienna, Vienna 1090, Austria., Freissmuth M; Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Waehringerstrasse 13a, Vienna 1090, Austria., Newman AH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States.
Publikováno v:
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2020 Aug 28; Vol. 4 (2), pp. 503-516. Date of Electronic Publication: 2020 Aug 28 (Print Publication: 2021).